Lion Point Capital, LP Milestone Pharmaceuticals Inc. Put Options Transaction History
Lion Point Capital, LP
- $9.73 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MIST
# of Institutions
52Shares Held
16.9MCall Options Held
341KPut Options Held
70.3K-
Black Rock Inc. New York, NY4.97MShares$7.41 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$3.73 Million0.03% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.45MShares$2.16 Million1.35% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.43MShares$2.13 Million0.56% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.14MShares$1.69 Million0.74% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $44.7M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...